Associations between DRRD and ISD and overall mortality (as continuous variables, adjusted for each other) were more apparent for postmenopausal, physically inactive women, with metastatic tumours, and in those with PR+, ER+ and HER2- (with DRRD), and ER- tumours (with ISD) (Table 3). This evidence concerns the gene ERBB2 and neoplasm.